Pharmaceutical Company

Taro, whose shares are up 25% in after-hours trading on May 26, has formed a special committee to evaluate the offer.

Merck CEO Kenneth Frazier to retire on June 30; CFO Robert Davis to be new chief

Frazier will continue to serve as executive chairman for Merck’s board of directors 'for a transition period to be determined by the board'.

Pharma companies to lose pandemic-induced pricing power in Q2 as economies reopen: Report

The pharma companies cumulatively saw their pre-tax margins rising by 306 basis points (bps) on an annualised basis and 551 bps sequentially in the first quarter due to better prices and lower expenses both due to the lockdowns, according to a report by India Ratings on Monday.

AstraZeneca to sell antibiotics business to Pfizer

The portfolio includes approved antibiotics Merrem, Zinforo and Zavicefta, and ATM-AVI and CXL, which are in clinical development, it said.

Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting

Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the presentation of data from the HERITAGE study at ...

Strides Shasun shares extend rally, up 2% as QIP opens

The pharmaceutical company has fixed floor price at Rs 1344.78 per share and says it may offer a discount of not more than 5 percent on floor price.

Kopran jumps 15% on shares allotment to promoter group co

Kopran allotted equity shares and warrants worth Rs 27.72 crore to its promoter group company.

Merck Q2 net down 38.87% at Rs 15.77 cr

The company had reported net profit of Rs 25.80 crore in the same quarter a year ago. Net sales in the quarter under review were at Rs 201.81 crore, an increase of 11.37 percent compared with Rs 181.2 in the corresponding quarter in the previous year.

Cipla completes buyout of Cipla Medpro for Rs 2,707 cr

Drug major Cipla completed the buyout process of Cipla Medpro for Rs 2,707 crore. With this move, it completed 100 percent acquisition of the issued shares of the South African company.

SP Tulsian's multibaggers: Sangam India, Bilcare

In an interview to CNBC-TV18 SP Tulsian of sptulsian.com picked Sangam India and Bilcare as multibagger stocks. He sees these stocks having the potential to fetch better returns going ahead.

Dr Reddy's Labs to acquire OctoPlus NV for euro 27.4m

Drug maker Dr Reddy's Laboratories today said it has decided to acquire Netherlands-based OctoPlus NV, a speciality pharmaceutical company, for about 27.4 million euros (about Rs 193 crore).

Biocon beats estimates, Q4 net down 3% YoY at Rs 98 cr

Pharmaceutical company Biocon has reported better than expected topline as well as bottomline numbers in its fourth quarter of FY12. Its net profit fell 3% to Rs 98 crore in the January-March quarter of 2012 from Rs 101 crore in a year ago period.

Acquired Uquifa for $55m; deal EPS accretive: Vivimed Labs

Pharmaceutical company, Vivimed Labs, has recently acquired Uquifa, a Spanish pharma company, for USD 55 million so as to expand business operations.

USFDA nod will open up lucrative market for us: Nectar Lifesciences

In an interview with CNBC-TV18, Dinesh Dua, CEO of Nectar Lifesciences said, "It’s going to happen at April. As soon as the approval is through we will be able to supply our API to lots of customers."

Blocking Ranbaxy's launch of cholesterol drug, where is the logic?

The US Foods and Drugs Administration (USFDA) will be sued by the US pharmaceutical company Mylan Inc, for an injunction on the launch of Ranbaxy’s cholesterol treatment drug Aricept, which is a generic version of Pfizer’s Lipitor.